Chong Wang

Guangzhou, 510515, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

NAT10 Promotes Prostate Cancer Growth and Metastasis by Acetylating mRNAs of HMGA1 and KRT8.

NAT10 Promotes Prostate Cancer Growth and Metastasis by Acetylating mRNAs of HMGA1 and KRT8.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 22, 2023

Correction: CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling.

Correction: CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling.

Journal: Molecular cancer
Published: October 23, 2023

SETD4 inhibits prostate cancer development by promoting H3K27me3-mediated NUPR1 transcriptional repression and cell cycle arrest.

SETD4 inhibits prostate cancer development by promoting H3K27me3-mediated NUPR1 transcriptional repression and cell cycle arrest.

Journal: Cancer letters
Published: August 18, 2023

Early Phase of Specific Cellular Immune Status Associates with HCV Infection Outcomes in Marmosets.

Early Phase of Specific Cellular Immune Status Associates with HCV Infection Outcomes in Marmosets.

Journal: Viruses
Published: March 27, 2023

CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling.

CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling.

Journal: Molecular cancer
Published: June 27, 2022

Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p.

Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p.

Journal: Molecular cancer
Published: September 18, 2021

SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer.

SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer.

Journal: Frontiers in cell and developmental biology
Published: March 10, 2021

The role of androgen therapy in prostate cancer: from testosterone replacement therapy to bipolar androgen therapy.

The role of androgen therapy in prostate cancer: from testosterone replacement therapy to bipolar androgen therapy.

Journal: Drug discovery today
Published: August 04, 2020

HMGB1 Promotes Prostate Cancer Development and Metastasis by Interacting with Brahma-Related Gene 1 and Activating the Akt Signaling Pathway.

HMGB1 Promotes Prostate Cancer Development and Metastasis by Interacting with Brahma-Related Gene 1 and Activating the Akt Signaling Pathway.

Journal: Theranostics
Published: February 11, 2019

Suppressed epithelial-mesenchymal transition and cancer stem cell properties mediate the anti-cancer effects of ethyl pyruvate via regulation of the AKT/nuclear factor-κB pathway in prostate cancer cells.

Suppressed epithelial-mesenchymal transition and cancer stem cell properties mediate the anti-cancer effects of ethyl pyruvate via regulation of the AKT/nuclear factor-κB pathway in prostate cancer cells.

Journal: Oncology letters
Published: January 26, 2018

Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasion.

Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasion.

Journal: Asian journal of andrology
Published: December 23, 2017

Fabrication of a hyaluronic acid conjugated metal organic framework for targeted drug delivery and magnetic resonance imaging.

Fabrication of a hyaluronic acid conjugated metal organic framework for targeted drug delivery and magnetic resonance imaging.

Journal: RSC advances
Published: December 01, 2017
Showing 1-12 of 13

Last Updated: 09/26/2026